Clari Vest Asset Management LLC Adverum Biotechnologies, Inc. Transaction History

Clari Vest Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$9.26 - $14.36 $209,359 - $324,665	-22,609 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$9.84 - $14.26 $303,928 - $440,448	-30,887 Reduced 57.74%	22,609 $246,000
Q3 2020 Nov 09, 2020	SELL	$10.3 - $21.64 $24,977 - $52,477	-2,425 Reduced 4.34%	53,496 $551,000
Q2 2020 Aug 12, 2020	SELL	$8.53 - $25.64 $228,723 - $687,510	-26,814 Reduced 32.41%	55,921 $1.17 Million
Q1 2020 May 04, 2020	BUY	$7.98 - $16.32 $660,225 - $1.35 Million	82,735 New	82,735 $809,000
Q4 2018 Feb 05, 2019	SELL	$2.87 - $5.92 $197,743 - $407,888	-68,900 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$4.5 - $7.6 $45,900 - $77,520	10,200 Added 17.38%	68,900 $416,000
Q2 2018 Aug 10, 2018	BUY	$5.3 - $6.9 $2,650 - $3,450	500 Added 0.86%	58,700 $311,000
Q1 2018 May 08, 2018	BUY	$3.65 - $7.95 $212,430 - $462,690	58,200 New	58,200 $337,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.